CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS
Revenue$106.1 billion+7.3% YoY
EPS$2.31
Outlookraisedguidance
Details · Original release on SEC.gov ↗ · Our research on CVS →
Collected automatically from companies' SEC filings (Form 8-K, Item 2.02)
Details · Original release on SEC.gov ↗ · Our research on CVS →
Forensic equity research on US stocks. No spam, unsubscribe anytime.